ZEPOSIA (Ozanimod) for the Treatment of Multiple Sclerosis
The safety and efficacy of Zeposia were demonstrated in Phase 3 SUNBEAM and RADIANCE Part B trials. Credit: Bristol Myers Squibb.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more